Exeliom Biosciences
- Address
- 67 Rue Des Godrans
Sponsor Overview
Specializations
Inflammatory Bowel Disease
Crohn's disease is the central therapeutic focus, with research activity directed toward maintaining clinical response and remission in patients with mild to moderate disease.
- Inflammation control
- Gastrointestinal immune modulation
- Maintenance of symptom relief
The sponsor's clinical research activity is concentrated in gastroenterology, particularly in treatment strategies relevant to inflammatory bowel disease and mucosal immune disorders.
Immunology
Research interest includes the modulation of immune-mediated inflammation, with attention to how therapeutic intervention may support sustained disease control in Crohn's disease.
- Immune response regulation
- Inflammatory pathway targeting
- Target engagement in immune disease
This area reflects involvement in therapies aimed at adjusting the underlying immunological drivers of chronic intestinal inflammation.
Gastroenterology
The sponsor's trial portfolio is focused on digestive system disease, with particular relevance to patients experiencing mild to moderate Crohn's disease and steroid-responsive disease states.
- Intestinal inflammation
- Maintenance therapy
- Steroid-induced clinical response
Clinical interest is centered on therapeutic approaches that support long-term management of chronic intestinal disorders.
Therapeutic Development
Research activity includes evaluation of a candidate therapy for target engagement and safety in the context of chronic inflammatory disease, indicating a focus on translational treatment development in autoimmune-related gastrointestinal conditions.
- Safety assessment
- Target engagement
- Novel treatment exploration
The sponsor is active in clinical investigation of therapies intended for immune-driven bowel disease.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase 1 Evaluation of EXL01 Safety and Target Engagement in Steroid-Induced Remission Maintenance for Mild to Moderate Crohn’s Disease |  Belgium Poland | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 10 sites across their trial portfolio.
Therapeutic Focus
- 1.Digestive System Diseases1 trial280 other sponsors
Partnered Research Centres
10 centres- Address
- Al. Tadeusza Rejtana 53, 35-326 Rzeszów
- Address
- ul. Inflancka 4 A, 00-189 Warsaw
- Address
- Domaine Universitaire du Sart-Tilman B35, 4000 Liège
- Address
- Ul. Boleslawa Chrobrego 6/8, 81-756 Sopot
- Address
- Ul. Onyksowa 10, 20-582 Lublin
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Exeliom Biosciences.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.